Jay Yang

Landscape Institute — United Kingdom

Medicine · Health Sciences

26h-index3.2kcitations181works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(60), Chronic Myeloid Leukemia Treatments(35), Lymphoma Diagnosis and Treatment(19), Myeloproliferative Neoplasms: Diagnosis and Treatment(19), Histone Deacetylase Inhibitors Research(17)

Publications181 total

Olutasidenib monotherapy in patients with mIDH1 Acute Myeloid Leukemia who received prior intensive chemotherapy
Blood·2025Open Access
Prognostic impact of pre-transplant IPSS-m risk downstaging in Myelodysplastic Syndromes
Blood·2025
Treatment free remission after asciminib (ABL001) based therapy in chronic Phase chronic myeloid leukemia (CP-CML) patients who relapsed after a prior attempt at TKI discontinuation-h jean khoury cure CML consortium study HJKC3-0003
Blood·2025Open Access
Multiomics-guided ex vivo drug sensitivity testing in Relapsed/Refractory Acute Myeloid Leukemia
Blood·2025Open Access
Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium
Blood·2025Open Access
Clinical characteristics and response in olutasidenib-treated Relapsed/Refractory mIDH1 Acute Myeloid Leukemia (AML) patients with stable disease following two treatment cycles
Blood·2025Open Access
Asciminib as initial therapy with addition of lower dose tyrosine kinase inhibitors (TKIs) for patients with chronic myeloid leukemia who do not achieve optimal response or a deep molecular remission
Blood·2025
A phase I dose escalation and expansion trial of lyt-200 (a First-In-Class Anti-Galectin-9 Antibody) alone and in combination with venetoclax/HMA in Relapsed/Refractory AML/MDS
Blood·2025Open Access
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase
Hematology·2025· 3 citedOpen Access
Inhibition of <scp>CDK</scp>9 enhances <scp>AML</scp> cell death induced by combined venetoclax and azacitidine
Molecular Oncology·2025Open Access
Decoding visual engagement in urban green spaces: A multisensory VR eye-tracking approach to vegetation-driven preference and perception
Building and Environment·2025· 1 cited
POSTER: AML-629 A Phase 2 Study of Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia: Outcomes by Number of Prior Treatment Regimens
Clinical Lymphoma Myeloma & Leukemia·2025
AML-629: A Phase 2 Study of Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia: Outcomes by Number of Prior Treatment Regimens
Clinical Lymphoma Myeloma & Leukemia·2025
Pregnancy modulates responses to male odors in house mice
Hormones and Behavior·2025
Olutasidenib alone or combined with azacitidine in patients with mutant <i>IDH1</i> myelodysplastic syndrome
Blood Advances·2025· 5 citedOpen Access
Older Jehovah’s Witnesses with Acute Myeloid Leukemia: Hypomethylating Agents and Venetoclax as a Transfusion-Sparing Approach
Hemato·2025Open Access
A phase 2 study of olutasidenib in relapsed/refractory acute myeloid leukemia: Outcomes by number of prior treatment regimens.
Journal of Clinical Oncology·2025
Urban restorative environments: The critical role of building density, vegetation structure, and multi-sensory stimulation in psychophysiological recovery
Building and Environment·2025· 9 cited
Abstract 4971: Predicting lung cancer screening adherence among underserved and minoritized communities using social determinants and neighborhood factors
Cancer Research·2025· 1 cited
Seasonality of the estrus cycle in laboratory mice under constant conditions
Laboratory Animals·2025· 1 cited
page 1 of 10Next →

Frequent Co-authors

Justin M. Watts(10), Shira Dinner(10), Jörge E. Cortes(8), Eunice S. Wang(7), Jennifer Sweeney(7), Maria R. Baer(7), William B. Donnellan(7), Grant W. Brown(6), Gary J. Schiller(6), P. Brent Ferrell(6), Patrick Kelly(6), Hesham Mohamed(6), Yongwei Su(5), Holly Edwards(5), Jeffrey W. Taub(5), Yubin Ge(5), Michael B. Maris(5), Andrew H. Wei(5), Pau Montesinos(5), Brian A. Jonas(5)